Condition
Maculopathy clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Maculopathy clinical trials that are recruiting, at sites in 4 countries (most in Singapore (1), Austria (1), United Arab Emirates (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
Home CRYSTALSIGHT gaze-tracking for monitoring maculopathy after anti-VEGF treatment
This will test whether the CRYSTALSIGHT home gaze-tracking device helps people aged 55–99 who finished anti‑VEGF injections for wet AMD or diabetic macular edema spot vision changes sooner than standard clinic follow-up.
-
Using stem cells to treat retinal and optic nerve damage
This study is testing if using stem cells from your own bone marrow can help improve vision in people with serious eye damage from conditions like age-related macular degeneration and optic nerve problems.
Related topics
Quick answers
How many Maculopathy clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Singapore (1 trial), Austria (1 trial), United Arab Emirates (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.